Acta Med. 2021, 64: 193-199
https://doi.org/10.14712/18059694.2022.1
Endoscopic Injection Treatment of Vesicoureteral Reflux in Children: Meeting with the Factors Involved in the Success Rate
Stylianos Roupakiasa,*
, Xenophon Sinopidisa, Ioannis Spyridakisb, George Tsikopoulosc, Ageliki Karatzad, Anastasia Varvarigoud
, Xenophon Sinopidisa, Ioannis Spyridakisb, George Tsikopoulosc, Ageliki Karatzad, Anastasia Varvarigoud
aDepartment of Pediatric Surgery, University of Patras Medical School, Patra, Greece
bDepartment of Pediatric Surgery, Aristotelian University of Thessaloniki Medical School, Thessaloniki, Greece
cDepartment of Pediatric Surgery, Hippocrateion General Hospital, Thessaloniki, Greece
dDepartment of Pediatrics, University of Patras Medical School, Patra, Greece
Received June 18, 2021
Accepted October 16, 2021
References
1. S, Sinopidis X, Karatza A, Varvarigou A. Predictive risk factors in childhood urinary tract infection, vesicoureteral reflux, and renal scarring management. Clin Pediatr 2014; 53: 1119–33.
<https://doi.org/10.1177/0009922813515744>
2. S, Sinopidis X, Tsikopoulos G, Spyridakis I, Karatza A, Varvarigou A. Dimercaptosuccinic acid scan challenges in childhood urinary tract infection, vesicoureteral reflux and renal scarring investigation and management. Minerva Urol Nefrol 2017; 69: 144–52.
3. P, Burgu B. Contemporary Management of Vesicoureteral Reflux. Eur Urol Foc 2017; 3: 181–8.
<https://doi.org/10.1016/j.euf.2017.08.012>
4. SW, Lee YS, Han SW. Endoscopic injection therapy. Investig Clin Urol 2017; 58: 38–45.
<https://doi.org/10.4111/icu.2017.58.S1.S38>
<PubMed>
5. E. Treatment of vesicorenal reflux by transurethral teflon- injection. Der Urologe Ausg A 1981; 20: 263–4.
6. b, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed) 1984; 289: 7–9.
<https://doi.org/10.1136/bmj.289.6436.7>
<PubMed>
7. A, Lackgrten G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: Experimental and short-term clinical result. J Urol 1995; 154: 800–3.
<https://doi.org/10.1016/S0022-5347(01)67168-4>
8. S, Gómez-Fraile A, Carrillo-Arroyo I, Tordable-Ojeda C, Cabezalí-Barbancho D. Endoscopic Treatment of Vesicoureteral Reflux in Infants. Can We Do It and Should We Do It? Urology 2017; 110: 196–200.
<https://doi.org/10.1016/j.urology.2017.08.005>
9. G, Kirsch AJ. Surgery Illustrated – Surgical Atlas Endoscopic treatment of vesicoureteral reflux. BJU Int 2010; 105: 1332–47.
<https://doi.org/10.1111/j.1464-410X.2010.09325.x>
10. N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P. Treatment of vesico-ureteric reflux: A new algorithm based parental preference. BJU Int 2003; 92: 285–8.
<https://doi.org/10.1046/j.1464-410X.2003.04325.x>
11. M, Bilgutay AN, Tollin N, et al. Long-Term clinical outcomes and parental satisfaction after Dextranomer/Hyaluronic acid (Dx/ HA) injection for primary vesicoureteral reflux. Front Pediatr 2019; 7: 392.
<https://doi.org/10.3389/fped.2019.00392>
<PubMed>
12. JW, Oh MM. Endoscopic treatment of vesicoureteral reflux in pediatric patients. Korean J Pediatr 2013; 56: 145–50.
<https://doi.org/10.3345/kjp.2013.56.4.145>
<PubMed>
13. L, Rovira J, Blazquez-Gomez E, et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen’s ureteral reimplantation for vesicoureteral reflux: long-term results. J Pediatr Urol 2013; 9: 483–7.
<https://doi.org/10.1016/j.jpurol.2013.03.003>
14. B, Natsheh A, Fridmans A, Shenfeld OZ, Farkas A. Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux. J Urol 2009; 182: 1703–7.
<https://doi.org/10.1016/j.juro.2009.03.011>
15. B, Berger C, Roesch J, et al. Persistence and recurrence of vesicoureteric reflux in children after endoscopic therapy – implications of a risk-adapted follow-up. Cent European J Urol 2015; 68: 389–95.
<https://doi.org/10.5173/ceju.2015.560>
<PubMed>
16. M, Esposito C, Escolino M, et al. Treatment of vesico-ureteral reflux in infants and children using endoscopic approaches. Transl Pediatr 2016; 5: 282–90.
<https://doi.org/10.21037/tp.2016.10.04>
<PubMed>
17. DA, Ludwig WW, Jayman JR, Akhavan A. The effect of prior endoscopic correction of vesicoureteral reflux on open ureteral reimplantation: Surgical outcomes and costs. J Pediatr Urol 2018; 14: 268.e1–5.
<https://doi.org/10.1016/j.jpurol.2018.01.023>
18. EK, Gatti JM, Demaro RT, Murphy JP. Long-term follow-up of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued follow up. J Urol 2009; 181: 1869–74.
<https://doi.org/10.1016/j.juro.2008.12.005>
19. HJ, Im YJ, Lee YS, Kim MJ, Han SW. Is a secondary procedure necessary in every case of failed endoscopic treatment for vesicoureteral reflux? Korean J Urol 2015; 56: 398–404.
<https://doi.org/10.4111/kju.2015.56.5.398>
<PubMed>
20. B, Natsheh A, Fadeev D, Shenfeld OZ, Farkas A. Unilateral vesicoureteral reflux warranting routine bilateral endoscopic correction. J Urol 2008; 180: 1601–3.
<https://doi.org/10.1016/j.juro.2008.03.095>
21. Y, Gulmez H, Güntekin E, Baykara M, Yucel S. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure. Scand J Urol 2014; 48: 565–70.
<https://doi.org/10.3109/21681805.2014.938695>
22. ST, Sung J, Skoog SJ. Endoscopic treatment for vesicoureteral reflux: how important is technique? J Pediatr Urol 2013; 9: 1192–7.
<https://doi.org/10.1016/j.jpurol.2013.05.002>
23. A, Serrano AJ, Magdalena JR, et al. The use of neural networks for predicting the result of endoscopic treatment for vesico- ureteric reflux. BJU Int 2004; 94: 120–2.
<https://doi.org/10.1111/j.1464-410X.2004.04912.x>
24. G. Endoscopic treatment of vesicoureteral reflux: Current status. Indian J Urol 2009; 25: 34–39.
<https://doi.org/10.4103/0970-1591.45534>
<PubMed>
25. JC, Reinberg Y, Ashley RA, et al. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/ hyaluronic acid injection. J Urol 2007; 178: 1702–5.
<https://doi.org/10.1016/j.juro.2007.03.174>
26. AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified sting procedure to correct vesicoureteral reflux: Improved results with submucosal implantation within the intramural ureter. J Urol 2004; 171: 2413–6.
<https://doi.org/10.1097/01.ju.0000127754.79866.7f>
27. TL, Chen Y, Nah SA, Ong CC, Jacobsen A, Low Y. STING versus HIT technique of endoscopic treatment for vesicoureteral reflux: A systematic review and meta-analysis. J Pediatr Surg 2016; 51: 2015–20.
<https://doi.org/10.1016/j.jpedsurg.2016.09.028>
28. OR, Yalçınkaya F, Altuğ U, Sertçelik N, Demirel F. Does the Modified STING Method Increase the Success Rate in the Management of Moderate or High-Grade Reflux? Korean J Urol 2014; 55: 615–9.
<https://doi.org/10.4111/kju.2014.55.9.615>
<PubMed>
29. S, Gupta A, Snodgrass W. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 2007; 177: 1505–9.
<https://doi.org/10.1016/j.juro.2006.11.077>
30. A, Snodgrass W. Intra-orifice versus hydrodistension implantation technique in dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 2008; 180: 1589–92.
<https://doi.org/10.1016/j.juro.2008.04.073>
31. WH, Scherz HC, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid in children. Adv Urol 2008; 513854: 1–7.
<https://doi.org/10.1155/2008/513854>
<PubMed>
32. B, Puri P. Endoscopic management of vesicoureteral reflux: does it stand the test of time? Eur Urol 2002; 42: 598–606.
<https://doi.org/10.1016/S0302-2838(02)00447-5>
33. S, Gómez-Fraile A, Carrillo-Arroyo I, et al. Factors involved in the late failure of endoscopic treatment of vesicoureteral reflux. Actas Urol Esp 2018; 42: 331–7.
<https://doi.org/10.1016/j.acuro.2017.11.006>
34. B, McAndrew F, Corbett H. A review of novel STING bulking agents. J Ped Urol 2019; 15: 484–90.
<https://doi.org/10.1016/j.jpurol.2019.08.018>
35. M, Ruiz E, Denes E, et al. New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: Preliminary results in children. J Urol 2010; 183: 714–7.
<https://doi.org/10.1016/j.juro.2009.10.047>
36. F, Omidi I, Haghdani S, Hatef Khorrami M, Izadpanahi MH, Mohammadi Sichani M. A comparison between dextranomer/ hyaluronic acid and polyacrylate polyalcohol copolymer as bulking agents for treating primary vesicoureteral reflux. Urol J 2019; 16: 174–9.
37. S, Krzemien G, Szmigielska A, Bombinski P, Brzewski M, Dudek-Warchol T. Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate- polyalcohol copolymer (Vantris). J Pediatr Urol 2016; 12: 256. e1–4.
<https://doi.org/10.1016/j.jpurol.2016.04.006>
38. H, Avlan D, Bahadir GB, Delibaş A, Nayci A. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux. Int Braz J Urol 2016; 42: 514–20.
<https://doi.org/10.1590/S1677-5538.IBJU.2015.0274>
<PubMed>
39. SC, User IR, Kılıc BD, Akçaer V, Ceylan H, Ozokutan BH. The comparison of dextranomer/hyaluronic acid and polyacrylate-polyalcohol copolymers in endoscopic treatment of vesicoureteral reflux. J Pediatr Surg 2016; 51: 1496–1500.
<https://doi.org/10.1016/j.jpedsurg.2016.02.092>
40. C. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children. J Pediatr Surg 2016; 51: 1711–5.
<https://doi.org/10.1016/j.jpedsurg.2016.03.013>
41. A, Yıldırım H, Özkan KU, Uçan B, Karkıner A, Hoşgör M. Late ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer. Urology 2014; 84: 1188–93.
<https://doi.org/10.1016/j.urology.2014.07.030>
42. AM, Sabetkish S, Khorramirouz R, Sabetkish N. Comparison of histopathological characteristics of polyacrylate polyalcohol copolymer with dextranomer/hyaluronic acid after injection beneath the bladder mucosa layer: a rabbit model. Int Urol Nephrol 2017; 49: 747–52.
<https://doi.org/10.1007/s11255-017-1540-z>
43. S, Krzemien G, Szmigielska A, Bombinski P, Τoth Κ, Dudek-Warchol T. Endoscopic correction of vesicoureteral reflux in children using polyacrylate-polyalcohol copolymer (Vantris): 5-years of prospective follow-up. Cent European J Urol 2017; 70: 314–9.
44. F, Shahdoost AA, Zargham M, Tadayon F, Joozdani RH, Arezegar. The influence of ureteral orifice configuration on the success rate of endoscopic treatment of vesicoureteral reflux. H Adv Biomed Res 2013; 2: 1.
45. W, Nam W, Lee C, et al. Long-term Outcomes of Endoscopic Anti- reflux Surgery in Pediatric Patients with Vesicoureteral Reflux: Urinary Tract Infection, Renal Scarring, and Predictive Factors for Success. J Korean Med Sci 2018; 33: e240.
<https://doi.org/10.3346/jkms.2018.33.e240>
<PubMed>
46. U, Cakan M, Yilmaz S, Yalçinkaya F. Are there predictive factors for the outcome of endoscopic treatment of grade III-V vesicoureteral reflux with dextranomer/hyaluronic acid in children? Pediatr Surg Int 2007; 23: 585–9.
<https://doi.org/10.1007/s00383-007-1881-2>
47. E, Sergio M, Casuccio A, Salerno S, Cimador M. Intraoperative ultrasound-assisted approach for endoscopic treatment of vesicoureteral reflux in children. J Pediatr Surg 2017; 52: 1661–5.
<https://doi.org/10.1016/j.jpedsurg.2017.04.004>
48. LS. The role of intraoperative cystography following the injection of dextranomer/hyaluronic acid copolymer. J Urol 2008; 179: 1118–20.
<https://doi.org/10.1016/j.juro.2007.10.087>
49. PJ, Reed F, Ovalle A, et al. Intraoperative cystography pre- and post-endoscopic treatment for vesicoureteral reflux: guaranteed success? J Pediatr Urol 2014; 10: 831–4.
<https://doi.org/10.1016/j.jpurol.2014.02.002>
50. FF, Tanno FY, Nguyen HT. Current options in the management of primary vesicoureteral reflux in children. Pediatr Clin North Am 2012; 59: 819–34.
<https://doi.org/10.1016/j.pcl.2012.05.012>
51. Roupakias S, Sinopidis X, Spyridakis I, Karatza A, Varvarigou A, Tsikopoulos G. The impact of our acquired experience on endoscopic injection treatment outcomes of vesicoureteral reflux during the first ten years of practice. J Renal Inj Prev 2021; In press (www.http://www.journalrip.com/Inpress).
52. AJ, Perez-Brayfield MR, Scherz HC. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/ hyaluronic acid copolymer: The Children’s Hospitals of Atlanta experience. J Urol 2003; 170: 211–5.
<https://doi.org/10.1097/01.ju.0000072523.43060.a0>
53. N, Lais A, Nappo S, Caione P. The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience. J Urol 2004; 172: 1626–8.
<https://doi.org/10.1097/01.ju.0000138381.75175.b9>
54. AJ, Pippi Salle JL, Barroso U, et al. What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol 2006; 176: 1851–5.
<https://doi.org/10.1016/S0022-5347(06)00599-4>
55. A, Olafsdottir T, Sköldenberg E, Barker G, Stenberg A, Läckgren G. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study. J Pediatr Urol 2020; 16: 328.e1–9.
<https://doi.org/10.1016/j.jpurol.2020.04.008>
56. JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics 2010; 125: 1010–9.
<https://doi.org/10.1542/peds.2009-2225>
57. JS, Diaz M, Caldamone AA, et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 2006; 175: 716–22.
<https://doi.org/10.1016/S0022-5347(05)00210-7>
58. JC, Reinberg Y. Predicting success in the endoscopic management of pediatric vesicoureteral reflux. Urology 2010; 76: 195–8.
<https://doi.org/10.1016/j.urology.2009.09.017>
59. M, Ciftci AO, Senocak ME, Tanyel FC, Buyukpamukcu N. Endoscopic Treatment of Vesicoureteral Reflux in Children: Our Experience and Analysis of Factors Affecting Success Rate. Urol Int 2008; 81: 41–6.
<https://doi.org/10.1159/000137639>
60. M, Todorić J, Budimir D, et al. Endoscopic treatment of vesicoureteral reflux in children with subureteral dextranomer/hyaluronic acid injection: a single-centre, 7-year experience. Can J Surg 2012; 55: 301–6.
<https://doi.org/10.1503/cjs.003411>
<PubMed>
61. P, Mohanan N, Menezes M, Colhoun E. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid. J Urol 2007; 178: 1714–6.
<https://doi.org/10.1016/j.juro.2007.03.172>
62. S, Gómez-Fraile A, Carrillo-Arroyo I, Tordable-Ojeda C, Cabezalí- Barbancho D. Endoscopic Treatment of Vesicoureteral Reflux in Infants. Can We Do It and Should We Do It? Urology 2017; 110: 196–200.
<https://doi.org/10.1016/j.urology.2017.08.005>
63. KL, Menon P, Samujh R, Mahajan JK, Bawa M, Malik MA, Mittal BR. Endoscopic Management of Vesicoureteral Reflux and Long-term Follow-up. Indian Pediatr 2018; 55: 1046–9.
<https://doi.org/10.1007/s13312-018-1439-5>
64. E, Pensabene M, Montano V, Casuccio A, Sergio M, Cimador M. Ultrasonographic mound height as predictor of vesicoureteral reflux resolution after endoscopic treatment in children. J Pediatr Surg 2016; 51: 1366–9.
<https://doi.org/10.1016/j.jpedsurg.2016.01.021>
65. H, Kim BS, Cheong HI, Cho BS, Kim KM. Long-term Results of Endoscopic Deflux Injection for Vesicoureteral Reflux in Children. Child Kidney Dis 2015; 19: 31–8.
<https://doi.org/10.3339/chikd.2015.19.1.31>
66. PZT, Abdelhalim A, Walia A, Wehbi E, Dave S, Khoury A. Avoiding routine postoperative voiding cystourethrogram: Predicting radiologic success for endoscopically treated vesicoureteral reflux. Can Urol Assoc J 2019; 13: 119–24.
67. R, Olivieri C, Briganti V, et al. Patients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up. Urol Ann 2012; 4: 19–23.
68. P, Kutasy B, Colhoun E, Hunziker M. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. J Urol 2012; 188: 1485–9.
<https://doi.org/10.1016/j.juro.2012.02.023>
69. JN, Lee SM, Ha YS, et al. VUR timing on VCUG as a predictive factor of VUR resolution after endoscopic therapy. J Pediatr Urol 2016; 12: 255.e1–6.
<https://doi.org/10.1016/j.jpurol.2016.04.002>
70. DS, Cambareri G, Alagiri M, Chiang G. Reflux Timing Is a Predictor of Successful Endoscopic Treatment of Vesicoureteral Reflux. Urology 2019; 124: 237–40.
<https://doi.org/10.1016/j.urology.2018.09.034>
71. T, Sharaf D, AbdelHalim A, Hafez A, Dawaba M. Can distal ureteral diameter predict reflux resolution after endoscopic injection? Urology 2015; 85: 896–9.
<https://doi.org/10.1016/j.urology.2014.12.021>
72. AD, Hoşgör M, Serdaroğlu E, Sencan A. Can distal ureteral diameter measurement predict primary vesicoureteral reflux clinical outcome and success of endoscopic injection? J Ped Urol 2019; 15: 515.e1–8.
<https://doi.org/10.1016/j.jpurol.2019.07.005>
73. L, Chan IHY, Chung PHY, Lan LCL, Tam PKH, Wong KKY. Endoscopic injection for primary vesicoureteric reflux: Predictors of resolution and long term efficacy. J Pediatr Surg 2017; 52: 2066–9.
<https://doi.org/10.1016/j.jpedsurg.2017.08.033>
74. CA, Skoog SJ, Arant BS Jr, et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol 2010; 184: 1134–44.
<https://doi.org/10.1016/j.juro.2010.05.065>
75. N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P. Influence of voiding dysfunction on the outcome of endoscopic treatment for vesicoureteral reflux. J Urol 2002; 168: 1695–8.
<https://doi.org/10.1016/S0022-5347(05)64391-1>
76. TW, Reiley EA, Ritch C, Murphy A. The clinical utility and safety of the endoscopic treatment of vesicoureteral reflux in patients with duplex ureters. J Pediatr Urol 2010; 6: 15–22.
<https://doi.org/10.1016/j.jpurol.2009.05.015>
77. M, Mohanan N, Puri P. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems. J Urol 2013; 189: 1876–81.
<https://doi.org/10.1016/j.juro.2012.11.048>
78. AM, Scherz HC, Filimon E, Leong T, J Kirsch AJ. Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux? J Pediatr Urol 2015; 11: 40.e1–5.
<https://doi.org/10.1016/j.jpurol.2014.11.011>
79. L, Paillet P, Minvielle T, et al. Long-Term (>10 Years) results after endoscopic injection therapy for vesicoureteral reflux. J Laparoendosc Adv Surg Tech A 2018; 2: 1408–11.
<https://doi.org/10.1089/lap.2018.0035>
80. RJF, Dietz HG, Stehr M. Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents. Pediatr Urol 2013; 9: 71–6.
<https://doi.org/10.1016/j.jpurol.2011.12.004>
81. A, Gupta A, Snodgrass W. Urinary tract infection following successful dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2008; 179: 1966–9.
<https://doi.org/10.1016/j.juro.2008.01.054>
82. M, Mohanan N, D’Asta F, Puri P. Incidence of febrile urinary tract infections in children after successful endoscopic treatment of vesicoureteral reflux: a long-term follow-up. J Pediatr 2012; 160: 1015–20.
<https://doi.org/10.1016/j.jpeds.2011.12.033>
